Featured news in The Life Sciences Report



Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Cancer Treatment Update: Second Gene Therapy Receives Approval (10/20/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
What's in the Cards for Amgen (AMGN) this Earnings Season? (10/20/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Gilead (GILD) CAR-T Therapy Yescarta Clinches FDA Approval (10/20/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Is a Beat in the Cards for Vertex (VRTX) in Q3 Earnings? (10/20/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Celgene Down on Discontinued Crohn's Disease Drug Study (10/20/2017)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Loblaw, CP at 52-Week Highs on News (4/27/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Inc. reaches new 52-Week High (5/8/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Designates PMN350 its Second Lead Product for Development in Alzheimer's Disease (5/24/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences to announce results in a presentation at the 2017 American Association of Neurology annual meeting (4/27/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Announces Q1 2017 Annual Results (5/9/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences to Present Preclinical Data from Alzheimer's Disease Program at AAIC 2017 (7/5/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Chief Scientific Officer, Dr. Neil Cashman, to present at Prion 2017 International Conference (5/25/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Help for Alzheimer's (6/2/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Daily Coverage on Healthcare Stocks: Spectral Medical, ProMIS Neurosciences, GeneNews, and Novadaq Technologies (6/19/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS(TM) Neurosciences' Sponsored Research Agreement with University of British Columbia Receives Matching Grant from Canadian Institutes of Health Research (7/6/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Prion 2017: Deciphering Neurodegenerative Disorders - 23-26 May 2017 Edinburgh (5/25/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Identifies Novel Therapeutic Epitope Target for ALS and Dementia (5/31/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS(TM) Neurosciences Appoints William C. Mobley to Scientific Advisory Board (6/6/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Provides Second Quarter Update for 2017 and Outlook for Near-Term Value Creation (7/10/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Announces CDN$3 Million Best-Efforts Private Placement (7/20/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Increases Size of Private Placement to $6 Million (8/2/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Completes First Closing of Private Placement (8/9/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Presents at AAIC 2017 Data from Alzheimer's Disease Program (7/19/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders (7/31/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Canadian Healthcare Stocks under Review, ProMIS Neurosciences, Spectral Medical, GeneNews, and Novadaq Technologies (8/2/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Announces Second Quarter 2017 Results (8/11/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Chief Scientific Officer, Dr. Neil Cashman, to Present at Third Annual R&D Technologies Conference (9/28/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Completes Second Closing of Private Placement (8/28/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Designates PMN330 as Third, Validated Lead Product for Development in Alzheimer's Disease (9/13/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Independent Director Anthony J. Giovinazzo Recognized with Inaugural Bloom Burton Award for Innovation in Canadian Healthcare (9/21/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Daily Coverage on Healthcare Stocks ProMIS Neurosciences Spectral Medical GeneNews and Sernova (10/9/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Report Coverage on Healthcare Stocks ProMIS Neurosciences Spectral Medical and GeneNews (9/7/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer's Disease (9/19/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Provides Third Quarter Update for 2017 (10/11/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences, Inc. (10/17/2017)

view
 

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences Lead Product Candidate, PMN310, Shows Desired Target Binding Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies for Alzheimer's Disease (10/17/2017)

view
 


DURECT Corp. (DRRX:NASDAQ)
DURECT Announces Top-line Results from the PERSIST Phase 3 Trial of POSIMIR® (SABER®-Bupivacaine) Did Not Meet Primary Efficacy Endpoint (10/19/2017)

view
 


RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB)
RepliCel Life Sciences Successfully Closes Financing (10/19/2017)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Corporate News Blog - Novan Acquires Intellectual Property Rights for Treating Viral Malignancies with Nitric Oxide (10/20/2017)

view
 


3D Signatures Inc. (DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE)
3D Signatures Announces Changes to Its Board of Directors and Audit Committee (10/19/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
The Zacks Analyst Blog Highlights: IBM, Celgene, Procter & Gamble, Valero and Sprint (10/19/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Top Stock Reports for IBM, Celgene and Procter & Gamble (10/18/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
New Clinical Evidence And A Landmark VLU Study To Be Presented At SAWC Fall Meeting (10/18/2017)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Featured Company News - Syndax Pharma Signs Worldwide License Agreement for Allergan's Portfolio of Menin-MLL Inhibitors (10/19/2017)

view